John Waldron
Internal Medicine · Medford, NJNPI 1154356343
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $995 and has fallen 98.5% since, to $15 in 2022.
Across 197 payments — averaging $12.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$437
- Amgen$251
- AstraZeneca$241
- Lilly USA, LLC$191
- AbbVie$179
- Pfizer$179
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,512100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 40 | $437 |
| Amgen | 19 | $251 |
| AstraZeneca | 18 | $241 |
| Lilly USA, LLC | 14 | $191 |
| AbbVie(2 entities) | 16 | $179 |
| Pfizer | 13 | $179 |
| Amarin Pharma, Inc. | 10 | $129 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $127 |
| Kowa Pharmaceuticals America, Inc. | 8 | $104 |
| Johnson & Johnson | 6 | $82 |
| Merck | 6 | $79 |
| Novartis | 5 | $69 |
| Boehringer Ingelheim | 4 | $54 |
| Novo Nordisk | 4 | $52 |
| Arbor Pharmaceuticals, Inc. | 3 | $46 |
| Adlon Therapeutics L.p. | 2 | $28 |
| Eisai Inc. | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Bausch Health US, LLC | 2 | $27 |
| Astellas Pharma US Inc | 2 | $27 |
| Aytu Biopharma, Inc. | 2 | $27 |
| Sanofi Pasteur Inc. | 2 | $23 |
| EMD Serono, Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Clarus Therapeutics Inc. | 1 | $15 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$2,518 in reported general payments places this provider in the 80th percentile of 4,032 internal medicine providers in New Jersey.
Other internal medicine in Medford
- James HoltonMedford$45K
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.